B
IRadimed Corporation IRMD
$70.32 $0.751.08% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 23.18% -8.93% 1.93% 3.03% 18.49%
Total Depreciation and Amortization 6.90% -0.41% -1.37% -0.75% -11.94%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -79.20% 242.96% -41.69% 182.61% -158.16%
Change in Net Operating Assets 170.12% -1,078.74% -93.21% 28.20% 220.31%
Cash from Operations 80.48% -28.31% -34.32% 37.32% 70.95%
Capital Expenditure 28.72% -32.52% 26.77% -235.89% -319.18%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 14.47% 17.55% -32.31% -48.71% 34.92%
Cash from Investing 27.92% -28.15% 23.80% -215.92% -165.20%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -100.00% --
Repurchase of Common Stock 17.45% 78.56% -2,947.75% 72.14% 0.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 0.00% -13.69% -0.04% -0.05% 76.18%
Other Financing Activities -- -- -- -- --
Cash from Financing 0.89% 5.78% -26.02% 2.14% 75.62%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 240.04% -471.03% -83.90% -6.53% 173.53%